Short-course systemic corticosteroids in asthma : striking the balance between efficacy and safety
| dc.contributor.author | Price, David | |
| dc.contributor.author | Castro, Mario | |
| dc.contributor.author | Bourdin, Arnaud | |
| dc.contributor.author | Fucile, Sebastian | |
| dc.contributor.author | Altman, Pablo | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2020-05-04T08:55:00Z | |
| dc.date.available | 2020-05-04T08:55:00Z | |
| dc.date.issued | 2020 | |
| dc.description | The authors thank Gillian Lavelle and Claire Twomey (Novartis Product Lifecycle Services, Dublin, Ireland) for providing scientific writing support for this article, which was funded by Novartis Pharma AG (Basel, Switzerland) in accordance with Good Publication Practice (GPP3) guidelines (www.ismpp.org/gpp3). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 315398 | |
| dc.identifier | 162463865 | |
| dc.identifier | 7ca342cb-5847-4ee1-b51d-a0807eb58607 | |
| dc.identifier | 32245768 | |
| dc.identifier | 85083041581 | |
| dc.identifier | 000528238600014 | |
| dc.identifier.citation | Price, D, Castro, M, Bourdin, A, Fucile, S & Altman, P 2020, 'Short-course systemic corticosteroids in asthma : striking the balance between efficacy and safety', European respiratory review : an official journal of the European Respiratory Society, vol. 29, no. 155, 190151. https://doi.org/10.1183/16000617.0151-2019 | en |
| dc.identifier.doi | 10.1183/16000617.0151-2019 | |
| dc.identifier.iss | 155 | en |
| dc.identifier.issn | 0905-9180 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14232 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85083041581&partnerID=8YFLogxK | en |
| dc.identifier.vol | 29 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European respiratory review : an official journal of the European Respiratory Society | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Adrenal Cortex Hormones/adverse effects | en |
| dc.subject | Anti-Asthmatic Agents/adverse effects | en |
| dc.subject | Asthma/drug therapy | en |
| dc.subject | Humans | en |
| dc.subject | Morbidity | en |
| dc.subject | Risk Factors | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | GLUCOCORTICOIDS | en |
| dc.subject | BONE-MINERAL DENSITY | en |
| dc.subject | CHILDREN | en |
| dc.subject | IMPACT | en |
| dc.subject | ORAL CORTICOSTEROIDS | en |
| dc.subject | OUTCOMES | en |
| dc.subject | APPROPRIATE USE | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Short-course systemic corticosteroids in asthma : striking the balance between efficacy and safety | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
